
Aster DM Healthcare is currently trading at Rs. 158.65, up by 0.55 points or 0.35% from its previous closing of Rs. 158.10 on the BSE.
The scrip opened
at Rs. 158.85 and has touched a high and low of Rs. 159.90 and Rs.
153.40 respectively. So far 2055 shares were traded on the counter.
The
BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of
Rs. 169.00 on 21-Jan-2019 and a 52 week low of Rs. 109.70 on
07-Aug-2019.
Last one
week high and low of the scrip stood at Rs. 162.75 and Rs. 153.40
respectively. The current market cap of the company is Rs. 7750.19
crore.
The promoters
holding in the company stood at 37.80%, while Institutions and
Non-Institutions held 17.63% and 44.57% respectively.
Aster
DM Healthcare is eyeing 25 percent of its total revenues from India
operations in the next 3-5 years as it undertakes a slew of initiatives
to scale up its business in the country. At present, around 85 percent
of company’s business comes from GCC region and around 15 percent from
India operations.
For
this, the company plans to increase the capacity utilisation of its
facilities in India from the current 60 percent to up to 75 percent
which is optimum. It will make significant improvements in the revenues.
In addition to this, the company is also entering into the diagnostics
segment in India.
Aster
DM Healthcare operates as a healthcare company in the Middle East,
India, and the Far East. It operates hospitals and clinics, pharmacies,
diagnostic centers, educational institutions, and healthcare management
and healthcare support systems.
0 comments:
Post a Comment
Please add comment